期刊文献+

静脉滴注药物中不溶性微粒的考察 被引量:25

Studies on Particulate Matter in Intravenous Admixture
暂未订购
导出
摘要 目的调研不同厂家、规格输液中不溶性微粒的基本情况;定量研究在静脉药物配置中心与普通病房复配的输液中不溶性微粒数量的差异;观察输液器对不溶性微粒的截留作用。方法采用光阻法对输液及在不同环境下配置的复配液进行微粒测定。结果不同厂家输液微粒存在显著性差异;在静脉药物中心内复配的药物微粒数较病房配置的明显减少;经过输液器后所有输液及复配液均符合中国药典关于>100 mL输液不溶性微粒质量标准。结论注射剂及大容量输液的质量、后期复配的环境、操作都是决定输液中微粒的重要因素。输液器是防止输液微粒进入人体的最后一道防线,其作用不容忽视。 OBJECTIVE To investigate the particulate producer matters in different transfusions from different producer, quanti the deviation between the count of particulate matters of the intravenous admixtures prepared in Pharmacy Intravenous Admixture (PIVA) preparing room and the count of unsoluable prepared in common wards and observe the interception of apparatus infusionis for those unsoluable particulates. METHODS The light bloekage method was used to record the count of particulate matters of the transfusions reconstituted in different environments. RESULTS The significant difference of transfusions from different producer was observed. The particulate matter count of the intravenous admixture prepared in PIVA was distinctly less than the count of those prepared in wards. The transfusions and those reconstituted via the apparatus infusionis all meet the limitation (for those volume ≥ 100 mL) of the standards of China Pharmacopeia. CONCLUSION The quality of the injections and high volume transfusions, the reconstituting environments are key factors for the count of particulate matter in the intravenous admixture. Furthermore the apparatus infusionis takes a significant role to prevent the particulate matter in transfusion from getting into human bodies.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第1期45-47,共3页 Chinese Pharmaceutical Journal
关键词 不溶性微粒 注射剂 配置环境 particulate matter injection reconstituting enviroument
  • 相关文献

参考文献1

共引文献50

同被引文献199

引证文献25

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部